Summit Therapeutics Inc (NASDAQ:SMMT) traded at $4.11 at close of the session on Monday, March 18, made a downward move of -10.93% on its previous day’s price.
Looking at the stock we see that its previous close was $4.62 and the beta (5Y monthly) reads -1.21 . In terms of its 52-week price range, SMMT has a high of $5.22 and a low of $1.30. The company’s stock has lost about -11.88% over that past 30 days.
Summit Therapeutics Inc has a market cap of $2.89 billion and is expected to release its quarterly earnings report on May 09, 2024 – May 13, 2024.
According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2021 is expected to hit $1.56 million, or -92.30% down from figures reported last year.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the SMMT stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Looking further, we note the current price level is -9.00% off its SMA20 and 0.99% from its 50-day simple moving average. The RSI (14) is pointing at 45.55 while the volatility over the past week is 9.82% and jumps to 11.95% over the past one month. The beta value is -1.19, while the average true range (ATR) is currently pointing at 0.45.
Coming back to Summit Therapeutics Inc (NASDAQ:SMMT), we note that the average 3-month trading volume was 2.13 million, while that of the preceding 10-day period stands at 3.01 million. Current shares outstanding are 701.66 million.
The insiders hold 88.13% of the company’s shares while institutions hold 4.64%. The data shows that short shares as of Feb 29, 2024, stood at 15.95 million at a short ratio of 7.71. This represents a 2.27% short interest in shares outstanding on Feb 29, 2024. Shares short rose in February from the previous month at 11.3 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 57.66% up in year-to-date price movement.
